Year: 2022

news_6

Elpiscience Announces FDA IND Clearance of ES014, a First-in-Class Anti-CD39xTGF-? Bispecific Antibody for Patients with Advanced Solid Tumors

SHANGHAI & SUZHOU, China & GERMANTOWN, Md.--(BUSINESS WIRE)--#CD39--Elpiscience Biopharmaceuticals, Inc. (“Elpiscience”), a clinical-stage biopharmaceutical company focused on developing next-generation immunotherapies...

news_6

2022 Report on Roofing Materials Markets in China – Historical Data (2011, 2016 and 2021) and Long-Term Forecasts Through 2026 and 2031 are Presented – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Roofing Materials Markets in China" report has been added to ResearchAndMarkets.com's offering. China's demand for Roofing Materials has...

news_6

Bio-Thera Solutions Announces First Patient Dosed in Australia for BAT7104, a Bispecific Antibody Targeting PD-L1 and CD47 for the Treatment of Advanced Solid Tumors

GUANGZHOU, China--(BUSINESS WIRE)--#AdvancedSolidTumors--Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase...